Pelvic wall involvement denotes a poor prognosis in T4 rectal cancer

被引:18
|
作者
Yiu, R [1 ]
Wong, SK [1 ]
Cromwell, J [1 ]
Madoff, RD [1 ]
Rothenberger, DA [1 ]
Garcia-Aguilar, J [1 ]
机构
[1] Univ Minnesota, Ctr Canc, Div Colon & Rectal Surg, Minneapolis, MN 55455 USA
关键词
rectal cancer; pelvic wall; locally advanced;
D O I
10.1007/BF02234389
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
PURPOSE: An aggressive surgical approach with en bloc resection of involved structures is often possible with anterior rectal cancers that invade adjacent visceral organs, but is rarely possible in tumors that invade the pelvic wall. However, most staging systems include both situations in the same group of T4 rectal cancers. We performed a retrospective study of patients with stage T4 rectal cancer undergoing surgery to assess the influence of different organ involvement on resectability and survival. METHODS: A retrospective review was conducted of 84 patients with T4 rectal cancer treated at the University of Minnesota and affiliated hospitals over a ten-year period. Forty-seven patients (56 percent) were staged for local invasion on the basis of final pathology, 19 (23 percent) on the basis of operative findings, and 18 (21 percent) on the basis of ultrasound images. Patients were divided into two groups, those with or without pelvic wall involvement. Resectability, local control, and overall survival were compared between groups. Survival curves were estimated by the Kaplan-Meier method and compared by log-rank test. Multivariate analysis was performed with Cox proportional and logistic regression. RESULTS: Thirty-one patients (37 percent) had involvement of the pelvic wall, whereas 53 patients (63 percent) had visceral involvement only. Ali 29 patients with distant metastasis died of their disease. Forty-seven of the 55 patients without distant metastasis underwent tumor resection. Age and pelvic wall involvement were the only two factors independently associated with the probability of resection in logistic regression analysis (P = 0.0067 and P = 0.037, respectively). The only factor that affected median survival in patients without distant metastasis was tumor resection (49.1 months for resection vs. 6.1 months for no resection. P = 0.017). Patients with visceral involvement had a longer median survival (49.2 months) than those with pelvic wall involvement (13.2 months), but the difference did not reach statistical significance (P = 0.058). CONCLUSION: Rectal cancers with pelvic and visceral involvement have different rates of resectability and median survival. These differences should be reflected in the TNM classification system.
引用
收藏
页码:1676 / 1681
页数:6
相关论文
共 50 条
  • [1] Survival after pelvic exenteration for T4 rectal cancer
    Kusters, M.
    Austin, K. K. S.
    Solomon, M. J.
    Lee, P. J.
    Nieuwenhuijzen, G. A. P.
    Rutten, H. J. T.
    [J]. BRITISH JOURNAL OF SURGERY, 2015, 102 (01) : 125 - 131
  • [2] Pelvic exenteration for t4 rectal cancer: A series of 15 resectable cases
    Pais Costa, S.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : VII121 - VII121
  • [3] Myelotoxicity of Preoperative Chemoradiotherapy Is a Significant Determinant of Poor Prognosis in Patients With T4 Esophageal Cancer
    Miyoshi, Norikatsu
    Yano, Masahiko
    Takachi, Ko
    Kishi, Kentaro
    Noura, Shingo
    Eguchi, Hidetoshi
    Yamada, Terumasa
    Miyashiro, Isao
    Ohue, Masayuki
    Ohigashi, Hiroaki
    Sasaki, Yo
    Ishikawa, Osamu
    Doki, Yuichiro
    Imaoka, Shingi
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2009, 99 (05) : 302 - 306
  • [4] Efficiency of multivisceral resection for T4 rectal cancer
    Shchepotin, I.
    Kolesnik, O.
    Prymak, V.
    Mahmudov, D.
    Beznosenko, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S545 - S545
  • [5] INFLUENCE OF LOCAL PERITONEAL INVOLVEMENT ON PELVIC RECURRENCE AND PROGNOSIS IN RECTAL-CANCER
    SHEPHERD, NA
    BAXTER, KJ
    LOVE, SB
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1995, 48 (09) : 849 - 855
  • [6] PELVIC EXENTERATIONS FOR T4 RECTAL CANCERS WITH SYNCHRONOUS PERITONEAL METASTASIS - IS IT SAFE?
    Mufaddal, M. K.
    Sukumar, V.
    Rohila, J.
    Desouza, A.
    Saklani, A.
    [J]. DISEASES OF THE COLON & RECTUM, 2022, 65 (05) : 228 - 228
  • [7] Outcome following extended resection for T4 rectal cancer
    Heriot, A
    Woods, R
    Ngan, S
    Tekkis, PP
    Mackay, J
    [J]. DISEASES OF THE COLON & RECTUM, 2006, 49 (05) : 775 - 775
  • [8] Impact of Lateral Pelvic Lymph Node Dissection on the Survival of Patients with T3 and T4 Low Rectal Cancer
    Ozawa, Heita
    Kotake, Kenjiro
    Hosaka, Miki
    Hirata, Akira
    Sugihara, Kenichi
    [J]. WORLD JOURNAL OF SURGERY, 2016, 40 (06) : 1492 - 1499
  • [9] T4 rectal cancer.: Surgery and multimodal therapy
    Rau, B
    Hohenberger, P
    Gellermann, J
    Hünerbein, M
    Hildebrandt, B
    Schneider, U
    Riess, H
    Wust, P
    Schlag, PM
    [J]. CHIRURG, 2002, 73 (02): : 147 - 153
  • [10] Impact of Lateral Pelvic Lymph Node Dissection on the Survival of Patients with T3 and T4 Low Rectal Cancer
    Heita Ozawa
    Kenjiro Kotake
    Miki Hosaka
    Akira Hirata
    Kenichi Sugihara
    [J]. World Journal of Surgery, 2016, 40 : 1492 - 1499